Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
Status:
Active, not recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This is a multicenter center, 2-arms prospective randomized phase II trial which evaluates
whether tocilizumab with gemcitabine/nab-paclitaxel is more effective than
gemcitabine/nab-paclitaxel.